Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Next-generation CRISPR genome editing • allogeneic CAR-T cell therapies • iPSC-derived NK cell therapies • oncology
51 - 200
💰 $125M Post-IPO Equity on 2023-07
2 days ago
🏢 In-office - Bay Area
⏳ Contract/Temporary
🔴 Lead
🔧 QA Engineer (Quality Assurance)
🛂 H1B Visa Sponsor
Go
💵 $180k - $195k / year
⏰ Full Time
🟠 Senior
🎯 Recruitment
💵 $225k - $245k / year
💰 Business Development (BDR)
Google Cloud Platform